Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Jan 2023 for Oyster Point Pharma, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Benjamin Tsai: trading record in brief
Benjamin Tsai is a declared insider of Oyster Point Pharma, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 7 June 2021 to 3 January 2023, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 4 January 2023, the filings show a transaction in Oyster Point Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Benjamin Tsai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,066 sharesCommon StockSEC:0001209191-23-001095:0
3,573 shares0Common StockSEC:0001209191-22-035061:0
3,466 shares0Common StockSEC:0001209191-21-039338:0
3 of 3 declarations
